(LYINR) Lyxor MSCI India Acc USD - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: FR0010375766
LYINR: India,Etf,Stocks,Diversified,Portfolio,Investment,Fund
The Lyxor MSCI India UCITS ETF Acc USD is a Swiss-based exchange-traded fund that tracks the Morningstar India TME NR USD index, providing investors with exposure to Indian equities. As an ETF categorized under India Equity, it allows for diversified investment in the Indian market.
From a technical standpoint, the ETF has shown a recent price of $31.83, slightly above its 20-day Simple Moving Average (SMA) of $31.69, indicating a potential bullish trend. The 50-day SMA at $30.57 further supports this, as the current price is significantly higher, suggesting an upward momentum. However, the 200-day SMA at $32.71 indicates that the ETF is still below its longer-term average, potentially signaling a resistance level. The Average True Range (ATR) of 0.52, or 1.65%, suggests a moderate level of volatility, which can be considered relatively stable for an India Equity ETF. The ETF has traded between $28.45 and $37.02 over the past 52 weeks, indicating a range of potential support and resistance levels.
Fundamentally, the Lyxor MSCI India UCITS ETF Acc USD has Assets Under Management (AUM) of $360.19 million, indicating a decent size that can provide liquidity to investors. The funds focus on tracking the Morningstar India TME NR USD index means its performance is closely tied to the overall Indian equity market, which has been a growth story for several years due to Indias economic expansion.
Combining both technical and fundamental data, a potential forecast for the Lyxor MSCI India UCITS ETF Acc USD could involve a cautious optimism. The ETFs recent price action and its position relative to its SMAs suggest a short-term bullish trend. However, its position below the 200-day SMA and the overall volatility of the Indian equity market, as indicated by the ATR, suggest that there could be challenges ahead. If the Indian economy continues to grow and the overall equity market performs well, the ETF could potentially break through its 52-week high of $37.02, driven by increased investor interest and capital inflows. Conversely, a downturn in the Indian market or global economic uncertainties could push the price back towards its 52-week low. Therefore, investors should closely monitor both the technical indicators and fundamental factors influencing the Indian equity market to make informed decisions.
Additional Sources for LYINR ETF
LYINR ETF Overview
Market Cap in USD | 360m |
Category | India Equity |
TER | 0.85% |
IPO / Inception | 2006-12-12 |
LYINR ETF Ratings
Growth Rating | 49.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -13.4 |
Analysts | - |
Fair Price Momentum | 33.95 USD |
Fair Price DCF | - |
LYINR Dividends
Currently no dividends paidLYINR Growth Ratios
Growth Correlation 3m | 80.4% |
Growth Correlation 12m | -68% |
Growth Correlation 5y | 81.5% |
CAGR 5y | 16.43% |
CAGR/Max DD 5y | 0.71 |
Sharpe Ratio 12m | -0.24 |
Alpha | -7.04 |
Beta | 0.418 |
Volatility | 16.42% |
Current Volume | 4.2k |
Average Volume 20d | 11.6k |
As of June 28, 2025, the stock is trading at USD 34.07 with a total of 4,185 shares traded.
Over the past week, the price has changed by +4.08%, over one month by +2.95%, over three months by +8.96% and over the past year by +0.19%.
Partly, yes. Based on ValueRay´s Analyses, Lyxor MSCI India Acc USD (SW:LYINR) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.62 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYINR is around 33.95 USD . This means that LYINR is currently overvalued and has a potential downside of -0.35%.
Lyxor MSCI India Acc USD has no consensus analysts rating.
According to our own proprietary Forecast Model, LYINR Lyxor MSCI India Acc USD will be worth about 37.7 in June 2026. The stock is currently trading at 34.07. This means that the stock has a potential upside of +10.68%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 37.7 | 10.7% |